[Edaily Starin YUN GI BACK Reporter] The group NouerA continued its upward momentum by taking first place on a terrestrial music show for the first time since their debut. NouerA (Photo: Screenshot from KBS2’s “Music Bank”) NouerA took home the No. 1 trophy on KBS2’s “Music Bank,” which aired on the 7th, with the title track of the same name from their fourth mini-album, “.exe.” Following their No. 1 win on MBC M and MBC every1’s “Show Champion” on the 5th, they further solidified their presence by securing their first No. 1 spot on a terrestrial music show. Immediately after receiving the award, the members of Nueara said, “We debuted on KBS, so we’re especially grateful to receive this meaningful award on the same channel,” and added, “We sincerely thank NovA (our fan club) for always being with us through both tough times and happy moments,” giving credit to their fans. That day, Nuera performed “EXE,” a track featuring an addictive synth sound. With a bright, energetic performance and subtle expressions that captured the song’s atmosphere, they conveyed a refreshing charm and drew an enthusiastic response from the audience. “EXE” is a song about confessing one’s feelings to a loved one without hesitation. She is also actively engaged in activities outside of music show appearances. Nuerra recently held a busking performance at COEX in Seoul to connect closely with fans, and has appeared on the web variety show “Idol Human Theater” and KBS’s “The Return of Superman—Dream Friends,” showcasing her natural charm offstage and expanding her fan base.
“The key point in the Jensen Huang scandal will ultimately be that data centers were built in China and elsewhere, and cloud services were provided to Chinese companies. Given the circumstances, this …
As the controversy surrounding Baek Jong-won, CEO of The BORN Korea, begins to subside, the company’s net loss for the third quarter of this year has narrowed significantly. The quarterly operating lo…
Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…